Atrium Therapeutics
IPOPaving a New Path for Precision Cardiology
Public · United States · Founded 2025 · $270.0M raised
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- atriumtherapeutics.com
- Total Funding
- $270.0M
- Last Round
- $270.0M Venture RoundFeb 2026
- Rounds
- 1
- Type
- Public
About
Precision RNA medicine biotech focused on rare genetic cardiomyopathies, launched with approximately $270 million.
Summary
Atrium Therapeutics is a Biotech company based in United States, founded in 2025. It has raised $270.0M in total across 1 round, most recently a $270.0M Venture Round round in Feb 2026.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...